Print
XClose
Press Information Bureau
Government of India
Ministry of Health and Family Welfare
19-November-2010 15:22 IST
Prevalence of HIV/AIDS
As per the HIV Estimations 2010, India is estimated to have 23

As per the HIV Estimations 2010, India is estimated to have 23.9 lakh people infected with HIV in 2009 at an estimated adult HIV prevalence of    0.31%. Adult HIV prevalence among men is 0.36%, while among women, it is 0.25%. The State-wise details of HIV prevalence among men and women and estimated number of HIV infections among men, women and children are annexed.

 

 National AIDS Control Organization (NACO) under National AIDS Control Programme Phase – III has developed a communication strategy to create awareness about HIV/AIDS and promote safe behaviors. Campaigns are conducted regularly on mass media supported by outdoor media such as hoardings, bus panels, information kiosks, folk theatre, and exhibition vans. At the inter-personal level, training and sensitization programmes for Self-Help Groups, Anganwadi Workers, ASHA, members of Panchayati Raj Institutions and other key stakeholders are carried out. Vulnerabilities of High Risk Groups including commercial sex workers (CSW), men having sex with men (MSM) , injecting drug users (IDU) and also truck drivers and migrants are specifically addressed through behavior change communication programmes implemented as part of Targeted Intervention (TI) projects. In addition, Integrated Counselling & Testing Centres (ICTC), STI clinics and Antiretroviral Therapy (ART) centres have provision of counseling and provide necessary information to clients approaching them.     NACO has also launched two phases of Red Ribbon Express project, in 2007-08 and 2009-2010 to generate awareness about HIV/AIDS across the country through a special exhibition train supported by outreach activities.   

 

 A Part of expenditure incurred in a financial year by Government of India towards implementation of National AIDS Control Programme (NACP-III) is reimbursed by the international agencies. The financial assistance received as reimbursement in the last three years and the current year are as follows.

2007-08 – Rs. 623.85 crore

2008-09 – Rs. 653.01 crore

2009-10 – Rs. 662.52 crore

2010-11 – Rs. 211.62 Crore (Till 13.11.2010)

 

 There is a tripartite agreement between the Indian Council of Medical Research (ICMR), the National AIDS Control Organisation (NACO) and the International AIDS Vaccine Initiative (IAVI) for carrying out HIV/AIDS vaccine research in India. The first agreement was signed in year 2000 and was extended further in 2005. The vaccine development agreement between IAVI and ICMR for the development and testing of the vaccines and tripartite agreement between NACO (GOI), ICMR, and IAVI would end by end of 2010. Under this agreement, the first HIV vaccine trial was conducted at NARI, Pune using Adeno-Associated Virus (AAV) based HIV-1 subtype C vaccine candidate; second trial at TRC, Chennai evaluated

Modified Vaccinia Ankara (MVA) based vaccine and the currently ongoing trial at TRC and NARI, Pune is evaluating a DNA-MVA prime boost strategy.

TBC-M4 vaccine has been manufactured by Therion Biologics Corporation, CombridgeMAUSA. ADVAX is manufactured as a sterile, purified plasmid DNA product by Vical Incorporated (San DiegoCA).

 


Annexure

Estimated Adult HIV Prevalence and Estimated number of HIV Infections among men, women and Children, State-wise, 2009

S.No

State

Estimated Adult HIV Prevalence

Estimated No. of HIV Infections

 

 

Male (%)

Female (%)

Male

Female

Children

(0-14 yrs)

1

Andaman & NicobarIslands

0.29

0.15

357

38

71

2

Andhra Pradesh

1.07

0.73

3,01,116

1,98,504

20,207

3

Arunachal Pradesh

0.2

0.12

686

395

42

4

Assam

0.1

0.06

8,883

5,360

330

5

Bihar

0.26

0.17

75,864

44,606

4,897

6

Chandigarh

0.46

0.29

2,059

1,008

1,454

7

Chhattisgarh

0.34

0.22

24,667

15,107

1,141

8

Dadra Nagar Haveli

0.17

0.12

173

112

11

9

Daman & Diu

0.18

0.13

156

95

10

10

Delhi

0.35

0.23

22,308

11,908

665

11

Goa

0.58

0.4

3,287

2,153

250

12

Gujarat

0.44

0.3

84,441

52,433

5,418

13

Haryana

0.17

0.07

8,118

7,734

388

14

Himachal Pradesh

0.23

0.16

5,400

3,478

118

15

Jammu & Kashmir

0.09

0.06

3,430

1,973

606

16

Jharkhand

0.16

0.1

14,904

8,670

871

17

Karnataka

0.75

0.51

1,48,089

97,433

9,475

18

Kerala

0.23

0.15

24,429

15,631

4,546

19

Madhya Pradesh

0.23

0.16

52,598

32,205

25

20

Maharashtra

0.64

0.45

2,56,679

1,63,110

23,831

21

Manipur

1.89

0.9

18,731

8,042

667

22

Meghalaya

0.1

0.07

824

508

131

23

Mizoram

0.97

0.64

3,822

2,203

1,762

24

Nagaland

0.94

0.61

8,481

4,639

267

25

Orissa

0.35

0.23

44,417

27,396

1,992

26

Puducherry

0.33

0.22

1,372

882

78

27

Punjab

0.37

0.26

36,111

20,816

3,909

28

Rajasthan

0.22

0.15

47,520

28,797

5

29

Sikkim

0.07

0.05

148

83

114

30

Tamil Nadu

0.39

0.27

93,023

61,719

6,749

31

Tripura

0.18

0.12

2,099

1,327

7,355

32

Uttar Pradesh

0.11

0.07

68,624

40,728

105

33

Uttarakhand

0.12

0.08

3,571

1,968

6,956

34

West Bengal

0.34

0.23

1,02,858

65,136

4

 

INDIA

0.36

0.25

14,69,245

9,26,197

1,04,450

 

This information was given by Minister for Health and Family Welfare Shri Ghulam Nabi Azad  in written reply to a question raised in Lok Sabha  today.

DS/GK